Citius Pharmaceuticals (CTXR) Misses Q2 EPS by 11c
Get Alerts CTXR Hot Sheet
Join SI Premium – FREE
Citius Pharmaceuticals (NASDAQ: CTXR) reported Q2 EPS of ($0.11).
For earnings history and earnings-related data on Citius Pharmaceuticals (CTXR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- NANO Nuclear Announces Participation in Several Investor Conferences
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
Citi, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share